Skip to main content

Table 4 Summary of mutational analysis in NSCLC patients with E2A-PBX1 fusion transcripts

From: Detection of E2A-PBX1 fusion transcripts in human non-small-cell lung cancer

   Total (%) K-P-E- K + P-E- K-P + E- K + P + E- K-P + E+ K-P-E+ K + P-E+ K + P + E+
Total   22 (100) 12 (54.5) 7 (31.8) 1 (4.5) 1 (4.5) 1 (4.5)    
Gender F 15 (100) 7 (46.7) 5 (33.3) 1 (6.7) 1 (6.7) 1 (6.7)    
  M 7 (100) 5 (71.4) 2 (28.6)       
Race Caucasian 16 (100) 8 (50.0) 5 (31.3) 1 (6.3) 1 (6.3) 1 (6.3)    
  Asian 3 (100) 2 (66.7) 1 (33.3)       
  Middle eastern 1 (100) 1 (100)        
  Hispanic 2 (100) 1(50.0) 1 (50.0)       
Smoking status NS 4 (100) 4 (100)        
  S 18 (100) 8 (44.4) 7 (38.9) 1 (5.6) 1 (5.6) 1 (5.6)    
Stage I 12 (100) 8 (66.7) 3 (25.0) 1 (8.3)      
  II 2 (100) 1 (50.0) 1 (50.0)       
  III 5 (100) 2 (40.0) 2 (40.0)    1 (20.0)    
  IV 3 (100) 1 (33.3) 1 (33.3)   1 (33.3)     
Histology AIS 16 (100) 8 (50.0) 5 (31.3) 1 (6.3) 1 (6.3) 1 (6.3)    
  Invasive Adc 5 (100) 3 (60.0) 2 (40.0)       
  LCC 1 (100) 1 (100)        
  1. K: k-ras codon 12; P: p53 exons 4-8; E: EGFR exons 19-21.